| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |